+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Insulin"

Diabetic Ketoacidosis - Pipeline Insight, 2024 - Product Thumbnail Image

Diabetic Ketoacidosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Adult-onset growth hormone deficiency - Pipeline Insight, 2024 - Product Thumbnail Image

Adult-onset growth hormone deficiency - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Diabetic Cardiomyopathy - Pipeline Insight, 2024 - Product Thumbnail Image

Diabetic Cardiomyopathy - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Graves' Orbitopathy - Pipeline Insight, 2024 - Product Thumbnail Image

Graves' Orbitopathy - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Somatotropin deficiency - Pipeline Insight, 2024 - Product Thumbnail Image

Somatotropin deficiency - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 80 Pages
  • Global
From
From
Empagliflozin Market Size, Forecast, and Emerging Insight - 2032 - Product Thumbnail Image

Empagliflozin Market Size, Forecast, and Emerging Insight - 2032

  • Report
  • February 2024
  • 30 Pages
  • Global
From
From
Glucagon-Like Peptide 1 Receptor Agonists - Pipeline Insight, 2024 - Product Thumbnail Image

Glucagon-Like Peptide 1 Receptor Agonists - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 100 Pages
  • Global
From
Somatostatin Receptor Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Somatostatin Receptor Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
ANGPTL3 protein inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

ANGPTL3 protein inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
PRV-031 Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

PRV-031 Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
RYZODEG Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

RYZODEG Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
LEVEMIR Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

LEVEMIR Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
From
From
From
From
From
From
Loading Indicator

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump. The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more